Soft Tissue Sarcoma Stocks List Ranked for 2024 |

Symbol	Grade	Name	% Change
MNPR	B	Monopar Therapeutics Inc.	0.41
PYXS	C	Pyxis Oncology, Inc.	5.62
SHPH	D	Shuttle Pharmaceuticals Holdings, Inc.	-10.70
IMMX	F	Immix Biopharma, Inc.	-0.63
TCON	F	TRACON Pharmaceuticals, Inc.	-2.91

Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic

Symbol	Grade	Name	Weight
IWC	B	iShares Microcap ETF	0.05
AVSC	C	Avantis U.S. Small Cap Equity ETF	0.02
EWX	A	SPDR S&P Emerging Markets Small Cap ETF	0.02
ITWO	D	ProShares Russell 2000 High Income ETF	0.01
IWM	B	iShares Russell 2000 ETF	0.01

Compare ETFs

Compare AVSC to EWX Compare IWC to ITWO Compare IWC to IWM

Date	Stock	Title
Oct 30	MNPR	Monopar Therapeutics Inc. Announces Closing of $19.2 Million Public Offering of Common Stock
Oct 30	SHPH	Why Alphabet Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket
Oct 30	SHPH	Shuttle Pharmaceuticals dips 6%, prices $4.5M share offering
Oct 30	SHPH	Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
Oct 29	SHPH	Shuttle Pharma Pays Off Senior Secured Convertible Note
Oct 29	SHPH	Shuttle Pharma Doses First Patients in Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma
Oct 29	SHPH	Why VF Corp Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket
Oct 29	MNPR	Monopar Therapeutics drops 16%, prices $19M offering at $16.25 per share
Oct 29	MNPR	Monopar Therapeutics Inc. Announces Pricing of $19.2 Million Public Offering of Common Stock
Oct 28	MNPR	Monopar Therapeutics proposes public offering of common stock
Oct 28	SHPH	Shuttle Pharma Completes Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with Glioblastoma
Oct 28	MNPR	Monopar Therapeutics Inc. Announces Proposed Public Offering of Common Stock
Oct 28	SHPH	Shuttle Pharmaceuticals to Present at the 2024 ThinkEquity Conference on Wednesday, October 30, 2024
Oct 28	MNPR	Why LENZ Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket

Soft Tissue Sarcoma: A soft-tissue sarcoma (STS) is a malignant tumour, a type of cancer, that develops in soft tissue. A soft tissue sarcoma is often a painless mass that grows slowly over months or years. They may be superficial or deep-seated. Any such unexplained mass will need to be diagnosed by biopsy. Treatment may include, surgery, radiotherapy, chemotherapy, and targeted drug therapy. The other type of sarcoma is a bone sarcoma.
There are many types. The World Health Organization lists more than fifty subtypes.